Ketamine- Propofol Versus Pethidine- Propofol in ERCP
Brief Summary
The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction.
Condition or Disease
- Sedation in ERCP
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years to 70 Years (Adult, Older Adult) |
| Enrollment: | 50 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Jan 15, 2020 | |
|---|---|---|
| Primary Completion: | Apr 16, 2020 | |
| Completion Date: | Apr 16, 2020 | |
| Study First Posted: | Jan 11, 2016 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Apr 29, 2016 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction, amount of propofol consumption Any desaturation or apnea will be recorded when the oxygen saturation (SpO2) dropped to <90% , time for recovery ,post-operative nausea and vomiting, hallucinations and Ramsey sedation scores of all patients will be recorded perioperatively. The Aldrete score was used to measure recovery from anesthesia at 5 and 10 min after the procedure.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 70 |
More Details
| NCT Number: | NCT02651792 |
|---|---|
| Other IDs: | ketfol versus pethidine |
| Study URL: | https://ClinicalTrials.gov/show/NCT02651792 |
Last updated: Jun 17, 2022